New patent for Nalpropion drug CONTRAVE

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are eighteen patents protecting…
The post New patent for Nalpropion drug CONTRAVE appeared fir…


New patent for Catalyst Pharms drug FIRDAPSE

Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on Dru…


Biotechblog